Your session is about to expire
← Back to Search
Tamsulosin for Urinary Retention
Study Summary
This trial will test whether tamsulosin can help women who need a hysterectomy to pee and be discharged sooner.
- Urinary Retention
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any eligibility requirements to join this trial?
"200 participants experiencing urinary retention aged between 18 and 80 have the opportunity to join this trial. Of particular note, female candidates aged 18-80 undergoing outpatient minimally invasive hysterectomy are eligible for enrolment."
What maladies can Tamsulosin be prescribed to address?
"Through the use of Tamsulosin, physicians are able to effectively treat bladder outlet obstruction, ureteral calculus, and benign prostatic hyperplasia (BPH)."
What other investigations involving Tamsulosin have been conducted thus far?
"Currently, 13 studies are underway to research Tamsulosin. Of these active trials, 3 have progressed into Phase 3. Most of the investigations for this drug take place in Baden-Aargau; however there are also clinical sites located elsewhere that carry out its testing."
Is this experiment seeking to enroll participants of a certain age threshold?
"This trial is enrolling individuals who are above the legal age of consent and below 80 years old."
Does this clinical research have any ongoing openings for participants?
"Affirmative. The information located on clinicaltrials.gov reveals that this medical trial is actively enrolling participants. Starting from April 16th 2021, the study has been recruiting for 200 patients distributed across 2 sites."
To what extent is this medical experiment being conducted with participants?
"Affirmative. According to the information hosted on clinicaltrials.gov, recruitment for this medical trial is still ongoing since it was first put up on April 16th 2021 and updated most recently May 17th 2022. The study needs 200 individuals from 2 different locations to take part in the research."
Has the FDA sanctioned Tamsulosin for therapeutic use?
"Since this is a Phase 2 trial, which indicates that Tamsulosin has been tested for safety but not efficacy, our team at Power estimated its safety as a score of two."
Share this study with friends
Copy Link
Messenger